EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Bright Future of mRNA as a Therapeutic Molecule

Dora Emma Vélez iD, Blanca Licia Torres iD, Greco Hernández iD

Genes · 2025

DOI: 10.3390/genes16040376 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2025. Verfasst von Dora Emma Vélez und 2 weiteren Autor:innen. Beteiligte Einrichtung: mRNA and Cancer Laboratory, Unit of Biomedical Research on Cancer, Instituo Nacional de Cancerología (National Institute of Cancer, INCan), Mexico Ci…. Hauptthemen laut MEDLINE: RNA, Messenger. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cancerología, Consejo Nacional de Humanidades, Ciencia y Tecnología (CONHACyT), CONHACyT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid success of messenger (m) RNA vaccines against COVID-19 has pushed the mRNA to the forefront of drug research. The promise of mRNA-based therapeutics and vaccines in other areas is not new but is now emerging stronger. We review basic concepts, key historical aspects, and recent research on mRNA as a therapeutic molecule to fight infectious diseases and cancer. We also show a current patent perspective of this field. Altogether, we describe that the technology of mRNA as a therapeutic molecule is a rapidly moving field aiming for a bright future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerHumansSARS-CoV-2COVID-19COVID-19 VaccinesCOVID-19 Drug TreatmentNeoplasmsAnimals

Stichwörter der Autor:innen

cancerdelivery systemsinfectious diseasesmRNAtherapeutic mRNA

Substanzen

RNA, MessengerCOVID-19 Vaccines

Autor:innen und Institutionen

  • mRNA and Cancer Laboratory, Unit of Biomedical Research on Cancer, Instituo Nacional de Cancerología (National Institute of Cancer, INCan), Mexico City 14080, Mexico.
  • Escuela de Medicina y Ciencias de la Salud, Tecnológico de Monterrey, Mexico City 14380, Mexico.

ORCID-Profile: Dora Emma Vélez, Blanca Licia Torres, Greco Hernández

Förderung

  • Instituto Nacional de Cancerología
  • Consejo Nacional de Humanidades, Ciencia y Tecnología (CONHACyT)
  • CONHACyT
  • intramural funding program of the National Institute of Cancer (Instituto Nacional de Cancerología, INCan)
  • SECIHTI fellowship

Zitieren

APA

Vélez, D. E., Torres, B. L., & Hernández, G. (2025). The Bright Future of mRNA as a Therapeutic Molecule. Genes. https://doi.org/10.3390/genes16040376

Vancouver

Vélez DE, Torres BL, Hernández G. The Bright Future of mRNA as a Therapeutic Molecule. Genes. 2025. doi:10.3390/genes16040376

BibTeX
@article{Vlez2025,
  author = {Vélez, Dora Emma and Torres, Blanca Licia and Hernández, Greco},
  title = {The Bright Future of mRNA as a Therapeutic Molecule},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16040376}
}
Kostenlos starten →